Advances in cellular and molecular radiation oncology

C. Norman Coleman, Mary Ann Stevenson

Research output: Contribution to journalReview articlepeer-review

Abstract

Radiation therapy remains a mainstay for the treatment of urologic malignancies, offering the opportunity for organ preservation as the primary treatment and serving in combination with surgery and systemic therapy for the more advanced tumors. Using prostate cancer as a model, classic radiation biology will be linked to the newer aspects of cellular and molecular biology of radiation oncology. Knowledge of classic radiation biology has provided new therapeutic approaches in dose fractionation, radiation sensitization, and normal tissue protection. Radiobiologic parameters derived from measuring radiation survival curves, tumor cell kinetics, and tumor oxygenation may provide the means to predict response to treatment. The basic mechanisms behind tumor and radiation biology that are under investigation include DNA recombination and repair, signal transduction, gene regulation, apoptosis, the cellular stress response, and the effect of the tumor microenvironment. The knowledge derived from improved understanding of the new biologic concepts, coupled with the superior technical capabilities now available for treatment delivery, is producing novel approaches in the clinic that may improve both the quality and quantity of life for the urologic cancer patient.

Original languageEnglish (US)
Pages (from-to)3-13
Number of pages11
JournalUrologic oncology
Volume2
Issue number1
DOIs
StatePublished - Jan 1 1996

Keywords

  • Radiation oncology
  • radiation biology

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Advances in cellular and molecular radiation oncology'. Together they form a unique fingerprint.

Cite this